This manuscript aims to present a treatment algorithm we applied to manage COVID-19 patients admitted to our hospital. During the study period, 2043 patients with suspected COVID-19 were admitted to the emergency department. Molecular tests indicated that 475 of these patients tested positive for COVID-19. We administered hydroxychloroquine plus doxycycline to mild cases (isolated at home) for 3 days and lopinavir plus doxycycline to moderate and severe cases (hospitalized) for 5 days. The overall case fatality rate was 4.2% (20/475).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452614 | PMC |
| http://dx.doi.org/10.1007/s10096-020-04016-1 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 patients
8
lopinavir doxycycline
8
novel approach
4
approach managing
4
covid-19
4
managing covid-19
4
patients
4
patients lopinavir
4
doxycycline cohort
4
cohort manuscript
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!